Results 261 to 270 of about 5,588,542 (410)

Using deep learning generated CBCT contours for online dose assessment of prostate SABR treatments

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract Prostate Stereotactic Ablative Body Radiotherapy (SABR) is an ultra‐hypofractionated treatment where small setup errors can lead to higher doses to organs at risk (OARs). Although bowel and bladder preparation protocols reduce inter‐fraction variability, inconsistent patient adherence still results in OAR variability.
Conor Sinclair Smith   +8 more
wiley   +1 more source

Integrating life cycle assessment into supply chain optimization. [PDF]

open access: yesPLoS One
Hülagü S   +4 more
europepmc   +1 more source

AAPM Task Group No. 249.B—Essentials and guidelines for clinical medical physics residency training program

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract The establishment of guidelines and curriculum standards for medical physics residency training is a critical component of setting expectations and competencies for the profession. Since the last publication of these standards, residency training has become integrated into the eligibility criteria for most medical physics certification bodies.
Jonathon A. Nye   +16 more
wiley   +1 more source

Supply Chain Management als strategische Herausforderung

open access: gold, 2000
Joachim Kodweiss, Keywan Nadjmabadi
openalex   +1 more source

A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT C‐truncating variants in the charged multivesicular body protein 2B (CHMP2B) gene are a rare cause of frontotemporal lobar degeneration (FTLD), previously identified only in Denmark, Belgium, and China. We report a novel CHMP2B splice‐site variant (c.35‐1G>A) associated with familial FTLD in Spain. The cases were two monozygotic male twins who
Sara Rubio‐Guerra   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy